Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Anthem (ANTM) Tops Q4 Earnings & Revenues, Issues '18 View By Zacks Investment Research - Jan 30, 2018

Anthem Inc.’s (NYSE:ANTM) fourth-quarter 2017 adjusted net income per share of $1.29 surpassed the Zacks Consensus Estimate of $1.25 by 3.2%. The bottom line, however declined 27% year over...

Zacks Investment Research
Simon Property (SPG) Q4 FFO Meets Estimates, Raises Dividend By Zacks Investment Research - Jan 30, 2018

Have you been eager to see how Simon Property Group Inc. (NYSE:SPG) performed in Q4 in comparison with the market expectations? Let’s quickly scan through the key facts from this Indianapolis,...

Zacks Investment Research
Hibbett (HIBB) Looks Bullish: Stock To Gain From Strategies By Zacks Investment Research - Jan 30, 2018

Hibbett Sports Inc. (NASDAQ:HIBB) is putting up a good show driven by its sturdy growth initiatives, improvement in the footwear and apparel businesses, strong ecommerce sales and extensive store...

Zacks Investment Research
National Oilwell (NOV) Q4 Earnings: Another Beat In Store? By Zacks Investment Research - Jan 30, 2018

National Oilwell Varco, Inc. (NYSE:NOV) is set to release fourth-quarter 2017 results after the closing bell on Feb 5.Houston, TX-based National Oilwell is a world leader in the designing,...

Zacks Investment Research
Puma & Medison Team Up To Commercialize Nerlynx In Israel By Zacks Investment Research - Jan 30, 2018

Puma Biotechnology, Inc. (NASDAQ:PBYI) and Medison Pharma Ltd — Israel's leading commercial partner for innovative pharmaceuticals — entered into an exclusive agreement to commercialize...

Zacks Investment Research
Mitsubishi UFJ (MTU) To Post Q3 Earnings: What's In Store? By Zacks Investment Research - Jan 30, 2018

Mitsubishi UFJ Financial Group (NYSE:MTU) is scheduled to report third-quarter fiscal 2018 (ended Dec 31, 2017) results on Feb 2.The banking giant of Japan reported profits attributable to owners of...

Zacks Investment Research
What's In The Cards For GW Pharma (GWPH) In Q1 Earnings? By Zacks Investment Research - Jan 30, 2018

GW Pharmaceuticals plc. (NASDAQ:GWPH) will report fiscal first-quarter 2018 results on Feb 5, before the market opens.GW Pharma’s share price has increased 20.8% over a year compared with the...

Zacks Investment Research
Invesco (IVZ) Beats Q4 Earnings As Revenues And AUM Rise By Zacks Investment Research - Jan 30, 2018

Invesco Ltd. (NYSE:IVZ) reported fourth-quarter 2017 adjusted earnings of 73 cents per share, outpacing the Zacks Consensus Estimate of 70 cents. Also, the bottom line came in 23.7% higher than the...

Zacks Investment Research
Central Garden & Pet's (CENT) Q1 Earnings: What's In Store? By Zacks Investment Research - Jan 30, 2018

Central Garden & Pet Company (NASDAQ:CENT) is slated to report first-quarter fiscal 2018 results on Feb 7, after the closing bell.The question lingering in investors’ minds is, whether...

Zacks Investment Research
Robert Half (RHI) Q4 Earnings & Sales Top Estimates, Up Y/Y By Zacks Investment Research - Jan 30, 2018

After posting back-to-back negative top and bottom-line surprises, Robert Half International Inc. (NYSE:RHI) came out with solid fourth-quarter 2017 results, wherein both top and bottom lines...

Continue with Apple
Continue with Google
or
Sign up with Email